LINCOLN NATIONAL CORP (LNC)
Sector: Financials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Financials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for LNC
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| LNC | Retired President, North American Pharmaceuticals of GlaxoSmithKline | 65 | ["business operations/strategic planning","finance and capital management","human capital management","corporate governance","Substantial leadership experience and expertise as a senior executive of large publicly traded companies with global operations","Extensive knowledge and expertise in strategy, operations, finance and capital management, brand marketing, product development and corporate governance","Insight in managing a large-scale diverse workforce as a former human resources executive"] | ["Audit","Compensation (Chair)","Corporate Governance","Executive","Compensation"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| M | Former President, North American Pharmaceuticals, GlaxoSmithKline | 65 | ["Senior Leadership", "Human Resources", "Marketing/Brand Management", "Leadership Experience \u2013 Ms. Connelly possesses many years of leadership experience as a senior executive of large publicly traded companies with global operations.", "Sales and Marketing Experience \u2013 Ms. Connelly\u2019s decades of experience in senior executive positions provide her with extensive knowledge and expertise in strategy, operations, product development, brand marketing and merchandising.", "R&D and Product Development \u2013 Ms. Connelly led an R&D global product development organization at Eli Lilly and Co-Chaired the Global Product Investment Board at GlaxoSmithKline for six years.", "Human Capital Management and Corporate Governance Experience \u2013 As a former Human Resources executive, Ms. Connelly has valuable insight in compensation/benefits oversight and managing a large-scale global workforce."] | ["CMD", "NCG"] | 2026 |
Biography sourced from the proxy statement filing.
Retired President, North American Pharmaceuticals of GlaxoSmithKline. Age: 65. Independent Director since: 2016. Committees: Audit; Compensation (Chair); Corporate Governance; Executive. Ms. Connelly was President, North American Pharmaceuticals of GlaxoSmithKline, a global pharmaceutical company, from 2009 until her retirement in 2015. Before that she served as President, U.S. Operations for Eli Lilly and Company from 2005 to 2009. Qualifications: Substantial leadership experience and expertise as a senior executive of large publicly traded companies with global operations. Ms. Connelly has extensive knowledge and expertise in strategy, operations, finance and capital management, brand marketing, product development and corporate governance. As a former human resources executive, she has insight in managing a large-scale diverse workforce. Other public company directorships (current): Macy's, Inc. (since 2008); Genmab A/S (since 2017); Sarepta Therapeutics, Inc. (since 2024). Former public company directorships (w/in past 5 years): N/A.